Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine

Clinical trial NCT04538040 · COMPLETED

Trial details

NCT number: NCT04538040
Sponsor: Quest Clinical Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2019-12-19
Primary completion: 2021-11-11
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.